+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Transcatheter Embolization & Occlusion Device Market by Product (Accessories, Embolization Coils, Embolization Particles), Application (Neurology, Oncology, Peripheral Vascular Disease), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5639421
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Transcatheter Embolization & Occlusion Device Market size was estimated at USD 5.29 billion in 2023, USD 5.94 billion in 2024, and is expected to grow at a CAGR of 12.76% to reach USD 12.28 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transcatheter Embolization & Occlusion Device Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transcatheter Embolization & Occlusion Device Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transcatheter Embolization & Occlusion Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc, Artio Medical, Inc., Becton Dickinson and Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer Inc., Sanofi SA, Siemens AG, Stryker Corporation, Terumo Corporation, and The 3M Company.

Market Segmentation & Coverage

This research report categorizes the Transcatheter Embolization & Occlusion Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Accessories
    • Embolization Coils
    • Embolization Particles
    • Flow Diverter Devices
    • Liquid Embolics
  • Application
    • Neurology
    • Oncology
    • Peripheral Vascular Disease
    • Urology
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Transcatheter Embolization & Occlusion Device Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transcatheter Embolization & Occlusion Device Market?
  3. What are the technology trends and regulatory frameworks in the Transcatheter Embolization & Occlusion Device Market?
  4. What is the market share of the leading vendors in the Transcatheter Embolization & Occlusion Device Market?
  5. Which modes and strategic moves are suitable for entering the Transcatheter Embolization & Occlusion Device Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Transcatheter Embolization & Occlusion Device Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for minimally invasive surgeries
5.1.1.2. Increased burden of targeted diseases
5.1.1.3. Surge in incidence of cardiovascular diseases and respiratory disorders
5.1.2. Restraints
5.1.2.1. High cost of products
5.1.3. Opportunities
5.1.3.1. Technological advances in the devices with enhanced efficiency
5.1.3.2. Increasing adoption of TEO devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory procedures for product commercialization
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Transcatheter Embolization & Occlusion Device Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Embolization Coils
6.4. Embolization Particles
6.5. Flow Diverter Devices
6.6. Liquid Embolics
7. Transcatheter Embolization & Occlusion Device Market, by Application
7.1. Introduction
7.2. Neurology
7.3. Oncology
7.4. Peripheral Vascular Disease
7.5. Urology
8. Transcatheter Embolization & Occlusion Device Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Hospitals
9. Americas Transcatheter Embolization & Occlusion Device Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transcatheter Embolization & Occlusion Device Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Transcatheter Embolization & Occlusion Device Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Agilent Technologies Inc
13.1.3. Artio Medical, Inc.
13.1.4. Becton Dickinson and Company
13.1.5. Boston Scientific Corporation
13.1.6. Edwards Lifesciences Corporation
13.1.7. Integer Holdings Corporation
13.1.8. Koninklijke Philips N.V.
13.1.9. Medtronic PLC
13.1.10. Merit Medical Systems, Inc.
13.1.11. Penumbra, Inc.
13.1.12. Pfizer Inc.
13.1.13. Sanofi SA
13.1.14. Siemens AG
13.1.15. Stryker Corporation
13.1.16. Terumo Corporation
13.1.17. The 3M Company
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET RESEARCH PROCESS
FIGURE 2. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2023 VS 2030
FIGURE 3. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET DYNAMICS
FIGURE 7. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY FLOW DIVERTER DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. JAPAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. JAPAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. JAPAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. THAILAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. THAILAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. THAILAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. DENMARK TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. DENMARK TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EGYPT TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. EGYPT TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. EGYPT TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. FINLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FINLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FINLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. NORWAY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. NORWAY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. NORWAY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. POLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. POLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. POLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. QATAR TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. TURKEY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. TURKEY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. TURKEY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Artio Medical, Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Integer Holdings Corporation
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Siemens AG
  • Stryker Corporation
  • Terumo Corporation
  • The 3M Company

Methodology

Loading
LOADING...

Table Information